Related Experiment Video

Updated: Jun 17, 2026

Yeast As a Chassis for Developing Functional Assays to Study Human P53
14:57

Yeast As a Chassis for Developing Functional Assays to Study Human P53

Published on: August 4, 2019

LMO3 interacts with p53 and inhibits its transcriptional activity

Steven Larsen1, Tomoki Yokochi, Eriko Isogai

  • 1Division of Biochemistry and Innovative Cancer Therapeutics, Chiba Cancer Center Research Institute, Chiba, Japan.

Biochemical and Biophysical Research Communications
|December 10, 2009
PubMed

Insights

High levels of LIM-only protein 3 (LMO3) drive aggressive neuroblastoma by interacting with and co-repressing the tumor suppressor p53. This study reveals LMO3

Area of Science:

  • Oncology
  • Molecular Biology
  • Gene Regulation

Background:

  • LIM-only protein 3 (LMO3) is linked to neuroblastoma development and aggressiveness.
  • Dysregulation of LIM-only proteins is implicated in human cancers.
  • The precise oncogenic mechanism of LMO3 has been unclear.

Purpose of the Study:

  • To investigate the molecular mechanism of LMO3 in oncogenesis.
  • To determine the interaction between LMO3 and the tumor suppressor p53.
  • To elucidate how LMO3 influences p53-dependent gene expression.

Main Methods:

  • In vitro and in vivo interaction assays to confirm LMO3 and p53 binding.
  • Analysis of p53 DNA-binding domain's role in the interaction.
  • Chromatin immunoprecipitation (ChIP) assays to assess LMO3's effect on p53 binding to DNA.
  • mRNA expression analysis of p53 target genes.

Main Results:

  • LMO3 directly interacts with p53, requiring p53's DNA-binding domain.
  • LMO3 suppresses the activation of p53 target gene promoters, reducing mRNA expression.
  • ChIP assays demonstrated that LMO3 enhances p53 binding to its response elements.
  • LMO3 functions as a co-repressor of p53, modulating its transcriptional activity.

Conclusions:

  • LMO3 acts as a co-repressor of p53, impacting its transcriptional regulation.
  • LMO3 suppresses p53-dependent gene expression without inhibiting p53's DNA-binding ability.
  • Understanding this LMO3-p53 interaction offers insights into neuroblastoma oncogenesis and potential therapeutic targets.

More Related Videos

Tropomodulin 3 Overexpression as a Marker for Platinum Resistance and Immune Infiltration in Ovarian Cancer09:40

Tropomodulin 3 Overexpression as a Marker for Platinum Resistance and Immune Infiltration in Ovarian Cancer

Published on: August 2, 2024

Purification of Ubiquitinated p53 Proteins from Mammalian Cells10:55

Purification of Ubiquitinated p53 Proteins from Mammalian Cells

Published on: March 21, 2022

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
Eukaryotic Transcription Inhibitors01:52

Eukaryotic Transcription Inhibitors

Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
Eukaryotic transcription inhibitors usually contain two distinct domains, a DNA...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
Master Transcription Regulators02:23

Master Transcription Regulators

Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a  complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...